Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20
去泛素酶 USP20 对 B-arrestin2 促动脉粥样硬化活性的调节
基本信息
- 批准号:8639259
- 负责人:
- 金额:$ 47.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-02-03 至 2018-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAnti-Inflammatory AgentsAnti-inflammatoryAntiatherogenicAntibodiesAtherosclerosisBindingBlood VesselsBreedingCause of DeathCell ProliferationCustomCytokine ReceptorsDeubiquitinationDietG-Protein-Coupled ReceptorsGene ExpressionGenesGoalsGrowth Factor ReceptorsHealthHumanHyperplasiaIRAK1 geneIn VitroInflammatoryInterleukin-1 ReceptorsIon ChannelIonsLinkMAPK3 geneMediatingMethodsModelingMolecularMusPhosphorylationPhosphotransferasesPhysiologicalPolyubiquitinationPost-Translational Protein ProcessingPreparationProcessProtein DephosphorylationProtein IsoformsProteinsReagentRegulationRoleSignal TransductionSignaling ProteinSmooth Muscle MyocytesStimulusSystemTNF geneTRAF2 geneTRAF6 geneTechniquesTestingTransgenic MiceTumor Necrosis Factor ReceptorUbiquitinationUnited Statesatherogenesisatheroprotectivebasecell motilitycongeniccytokinefeedingin vivointerleukin-1 receptor-associated kinasemigrationnew therapeutic targetnovelpreventpromoterprototyperesponsescaffoldstress-activated protein kinase 1toll-like receptor 4transcription factorubiquitin-protein ligaseubiquitin-specific protease
项目摘要
DESCRIPTION (provided by applicant): Atherosclerosis remains a leading cause of death in the United States. Accumulating evidence suggests that aortic wall smooth muscle cell gene expression contributes substantially to atherogenesis. ß-arrestin2 (ßarr2) an endocytic and signaling adaptor for G protein-coupled receptors (GPCRs), growth factor receptors and ion- channels is also known to promote neointimal hyperplasia and atherosclerosis in mice. Reversible ßarr2 ubiquitination, as regulated by deubiquitinases (DUBs) is a critical post-translational modification that is required for ßarr2's adaptor functions in mediating cell-signaling. Our Preliminary Studies suggests that the DUB USP20 might affect ßarr2 ubiquitination as well as NFκB signaling induced by the atherogenic Toll-like receptor 4 (TLR4). To delineate the role(s) of ßarr2 ubiquitination/deubiquitination dynamics in vivo and to evaluate whether the ubiquitination status of ßarr2 could engender pro-inflammatory signaling in SMCs, we have generated transgenic mice expressing USP20 or its catalytically inactive isoform (DN-USP20) under control of the SMC-specific SM22α promoter. In this model, we expect that by de-ubiquitinating ßarr2, USP20 would reduce ßarr2 activity and thereby reduce the SMC pro-atherogenic proliferation and migration that engenders neointimal hyperplasia, whereas the DN-USP20 would have reciprocal effects. By utilizing these and additional novel reagents and in vivo methods involving diet and gene-dependent atherosclerosis and in vitro techniques employing primary vascular smooth muscle cells we will test the hypotheses that USP20 in SMCs mitigates atherosclerosis through mechanisms involving deubiquitination of ßarr2, and/or deubiquitination of TRAF6 or TRAF2 in a manner dependent upon ßarr2 scaffolding by accomplishing following specific aims: (1) To determine the atheroprotective role of SMC USP20, and whether USP20's mechanism of action requires de-ubiquitination of ßarr2 (2) To determine whether USP20 activity regulates ßarr2-dependent SMC proliferation, migration and signaling triggered by inflammatory stimuli and (3) To elucidate the mechanistic basis of USP20's effects on ßarr2-dependent signaling.
描述(由适用提供):动脉粥样硬化仍然是美国的主要死亡原因。积累的证据表明,主动脉壁平滑肌细胞基因表达对动脉粥样硬化有很大贡献。 ß-arrestin2(ßarr2)G蛋白偶联受体(GPCR),生长因子受体和离子通道的内吞和信号衔接子也已知小鼠的新内膜增生和动脉粥样硬化。由去泛素酶(DUBS)调节的可逆ßarr2泛素化是一种关键的翻译后修饰,是ßarr2的适配器在介导细胞信号时所必需的。我们的初步研究表明,DUB USP20可能会影响ßarr2泛素化以及由动脉粥样硬化Toll样受体4(TLR4)诱导的NFκB信号传导。要描述体内泛泛素化/去泛素化动力学的作用,并评估ßarr2的泛素化状态是否可以在SMC中引起促发炎信号,我们已经在USP20产生了转基因小鼠,表达了USP20或表达其催化性的SPERMOFERMEFERM(DN-SPEC22)。在该模型中,我们预计,通过去泛素化β2,USP20将减少ßarr2活性,从而减少SMC亲动脉粥样硬化的增殖和迁移,从而导致新的增生增生,而DN-USP20会产生相互影响的效果。 By utilizing these and additional novel reagents and in vivo methods involving diet and gene-dependent atherosclerosis and in vitro techniques employing primary vascular smooth muscle cells we will test the hypotheses that USP20 in SMCs mitigates atherosclerosis through mechanisms involving deubiquitination of ßarr2, and/or deubiquitination of TRAF6 or TRAF2 in a manner dependent upon ßarr2通过实现特定目的进行脚手架:(1)确定SMC USP20的动脉保护作用,以及USP20的作用机理是否需要对ßarr2(2)的泛素化进行去泛素化,以调节USP20活性确定eplym2依赖性SMC的迁移和信号的效果是否触发了(3)的机构(3) ßarr2依赖性信号传导。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NEIL J. FREEDMAN其他文献
NEIL J. FREEDMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NEIL J. FREEDMAN', 18)}}的其他基金
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis
小核仁 RNA 加剧动脉粥样硬化的机制
- 批准号:
10502380 - 财政年份:2022
- 资助金额:
$ 47.46万 - 项目类别:
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis
小核仁 RNA 加剧动脉粥样硬化的机制
- 批准号:
10670399 - 财政年份:2022
- 资助金额:
$ 47.46万 - 项目类别:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
去泛素酶 USP20 对血管炎症信号的调节
- 批准号:
9765984 - 财政年份:2019
- 资助金额:
$ 47.46万 - 项目类别:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
去泛素酶 USP20 对血管炎症信号的调节
- 批准号:
9893026 - 财政年份:2019
- 资助金额:
$ 47.46万 - 项目类别:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
去泛素酶 USP20 对血管炎症信号的调节
- 批准号:
10349573 - 财政年份:2019
- 资助金额:
$ 47.46万 - 项目类别:
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20
去泛素酶 USP20 对血管炎症信号的调节
- 批准号:
10112295 - 财政年份:2019
- 资助金额:
$ 47.46万 - 项目类别:
Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20
去泛素酶 USP20 对 B-arrestin2 促动脉粥样硬化活性的调节
- 批准号:
8797106 - 财政年份:2014
- 资助金额:
$ 47.46万 - 项目类别:
相似国自然基金
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卡萨烷选择性调控糖皮质激素受体GR功能的抗炎作用机制与新颖调控剂的设计与发现
- 批准号:82273824
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:82204218
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:82103973
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Hormone Therapy for Peri- and Postmenopausal Women with HIV (HoT)
感染艾滋病毒的围绝经期和绝经后妇女的激素治疗 (HoT)
- 批准号:
10698682 - 财政年份:2023
- 资助金额:
$ 47.46万 - 项目类别:
Impacts of Acute Ambient Air Pollution Exposure on Women's Reproductive Health: Identifying Mechanisms and Susceptible Reproductive Processes Across the Menstrual Cycle and Early Pregnancy
急性环境空气污染暴露对女性生殖健康的影响:确定月经周期和怀孕早期的机制和易受影响的生殖过程
- 批准号:
10645818 - 财政年份:2023
- 资助金额:
$ 47.46万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 47.46万 - 项目类别:
Role of Creatine Metabolism in Necrotizing Enterocolitis
肌酸代谢在坏死性小肠结肠炎中的作用
- 批准号:
10724729 - 财政年份:2023
- 资助金额:
$ 47.46万 - 项目类别:
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 47.46万 - 项目类别: